Issue 33, 2017

Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature

Abstract

Angiogenesis is a dynamic process fundamental to the development of solid tumors. Epidermal growth factor-like domain 7 (EGFL7) is a protein whose expression is restricted to endothelial cells undergoing active remodeling that has emerged as a key mediator of this process. EGFL7 expression is associated with poor outcome in several cancers, making it a promising target for imaging or therapeutic strategies. Here, EGFL7 is explored as a molecular target for active neovascularization. Using a combinatorial peptide screening approach, we describe the discovery and characterization of a novel high affinity EGFL7-binding peptide, E7p72, that specifically targets human endothelial cells. Viral nanoparticles decorated with E7p72 peptides specifically target tumor-associated neovasculature with high specificity as assessed by intravital imaging. This work highlights the value of EGFL7 as a target for angiogenic vessels and opens the door for novel targeted therapeutic approaches.

Graphical abstract: Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature

Supplementary files

Article information

Article type
Paper
Submitted
10 Apr 2017
Accepted
31 Jul 2017
First published
01 Aug 2017
This article is Open Access
Creative Commons BY-NC license

Nanoscale, 2017,9, 12096-12109

Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature

C. Cho, L. Yu, T. K. Nsiama, A. N. Kadam, A. Raturi, S. Shukla, G. A. Amadei, N. F. Steinmetz, L. G. Luyt and J. D. Lewis, Nanoscale, 2017, 9, 12096 DOI: 10.1039/C7NR02558K

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements